A Synthetic Triple Helical Collagen Peptide as a New Agonist for Flow Cytometric Measurement of GPVI-Specific Platelet Activation

Abstract

Synthetic cross-linked collagen-related peptide (CRP-XL) is a glycoprotein VI (GPVI) receptor activator for platelet activation. This triple helical peptide, widely used in platelet function tests, is synthesized and cross-linked through cysteine residues at its N-terminus and C-terminus. Currently, there is only one laboratory, which is capable to produce this valuable peptide for clinical applications. In an attempt to provide a standardized alternative for CRP-XL, we developed a synthetic triple helical collagen peptide (STH-CP) with the same primary sequence as CRP-XL (GPC-(GPO)₁₀-GPCG-amide)₃, which was both on the C-terminus and on the N-terminus fixed on a scaffold with a binding side for each of the three peptides. The performance of STH-CP on platelet function was studied using flow cytometry and compared with CRP-XL. We found that platelet activation pattern in response to STH-CP and CRP-XL is similar, although the STH-CP requires sixfold higher concentrations to activate platelets to the same state. The intra-assay percent coefficient of variation of STH-CP and CRP-XL were both < 5% and the interindividual variation measured in 118 individuals for both peptides was around 23 and 21% for αIIbβ3 activation and P-selectin expression, respectively. The STH-CP in ready-to-use reaction mix has lower variation than CRP-XL over 1-year storage. In reference values and seasonal variation study, the platelet activation response showed a strong correlation between STH-CP and CRP-XL.

Our findings show that this new STH-CP is a stable and potent platelet GPVI agonist which can induce the same reproducible platelet activation as CRP-XL and that STH-CP can be considered as a good alternative for CRP-XL.

Keywords

platelet activation - cross-linked collagen-related peptide - synthetic triple helical collagen peptide

• References

• 1 de Groot PG, Urbanus RT, Roest M. Platelet interaction with the vessel wall. Handb Exp Pharmacol 2012; (210) 87-110
• 2 Cattaneo M, Cerletti C, Harrison P. , et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost 2013; 11: 1183-1189
• 3 Knight CG, Farndale RW. Peptide Synthesis in the Study Of Collagen–Platelet Interactions. In: Walker JM. , ed. New Jersey: Humana Press Inc.; 2004: 490
• 4 Corredor C, Wasowicz M, Karkouti K, Sharma V. The role of point-of-care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta-analysis. Anaesthesia 2015; 70 (06) 715-731
• 5 Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 2006; 35 (1-2): 67-82
• 6 van Asten I, Schutgens REG, Baaij M. , et al. Validation of flow cytometric analysis of platelet function in patients with a suspected platelet function defect. J Thromb Haemost 2018; 16 (04) 689-698
• 7 Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274 (41) 29019-29024
• 8 Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003; 102 (02) 449-461
• 9 Kanaji S, Kanaji T, Furihata K, Kato K, Ware JL, Kunicki TJ. Convulxin binds to native, human glycoprotein Ib alpha. J Biol Chem 2003; 278 (41) 39452-39460
• 10 Asselin J, Knight CG, Farndale RW, Barnes MJ, Watson SP. Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI. Biochem J 1999; 339 (Pt 2): 413-418
• 11 Prockop DJ, Kivirikko KI. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 1995; 64: 403-434
• 12 Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α 2 β 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α 2 β 1-independent platelet reactivity. Biochem J 1995; 306 (Pt 2): 337-344
• 13 Achison M, Joel C, Hargreaves PG, Sage SO, Barnes MJ, Farndale RW. Signals elicited from human platelets by synthetic, triple helical, collagen-like peptides. Blood Coagul Fibrinolysis 1996; 7 (02) 149-152
• 14 Asselin J, Gibbins JM, Achison M. , et al. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C γ2 in platelets independent of the integrin α2β1. Blood 1997; 89 (04) 1235-1242
• 15 Huskens D, Sang Y, Konings J. , et al. Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test. PLoS One 2018; 13 (02) e0192079
• 16 Polanowska-Grabowska R, Gibbins JM, Gear AR. Platelet adhesion to collagen and collagen-related peptide under flow: roles of the [α]2[β]1 integrin, GPVI, and Src tyrosine kinases. Arterioscler Thromb Vasc Biol 2003; 23 (10) 1934-1940
• 17 Knight CG, Morton LF, Onley DJ. , et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 1999; 41 (02) 450-457
• 18 Lombardi F, De Chaumont C, Shields DC, Moran N. Platelet signalling networks: pathway perturbation demonstrates differential sensitivity of ADP secretion and fibrinogen binding. Platelets 2012; 23 (01) 17-25
• 19 Garner SF, Furnell A, Kahan BC. , et al. Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time. Vox Sang 2017; 112 (01) 18-24
• 20 Kicken CH, Roest M, Henskens YM, de Laat B, Huskens D. Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): monitoring platelet activation in platelet concentrates. PLoS One 2017; 12 (02) e0172265
• 21 Roest M, van Holten TC, Fleurke GJ, Remijn JA. Platelet activation test in unprocessed blood (Pac-t-UB) to monitor platelet concentrates and whole blood of thrombocytopenic patients. Transfus Med Hemother 2013; 40 (02) 117-125
• 22 Timmerman P, Puijk WC, Meloen RH. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology. J Mol Recognit 2007; 20 (05) 283-299
• 23 LSI. Measurement Procedure Comparison and Bias Estimation Using Patient Samples; Approved Guideline—Third Edition. CSLI Doc. EP093A 33, (2013)
• 24 Savage B, Ginsberg MH, Ruggeri ZM. Influence of fibrillar collagen structure on the mechanisms of platelet thrombus formation under flow. Blood 1999; 94 (08) 2704-2715